Syncona Limited
Overview
Syncona Limited is a FTSE250 healthcare investment trust focused on founding, building, and funding a portfolio of global leaders in life science to deliver transformational treatments to patients.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Therapeutics | Jul 2024 | Series B | Co-investor |
| Purespring Therapeutics | Oct 2024 | Series B | Co-investor |
| iOnctura | Jun 2024 | Series B | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Syncona Limited based?
Headquarters information for Syncona Limited is not publicly available.
When was Syncona Limited founded?
Syncona Limited was founded in 2012.
How many portfolio companies does Syncona Limited have?
Syncona Limited has 5 portfolio companies in Caplight's dataset.
What are some companies in Syncona Limited's portfolio?
Portfolio companies visible on Caplight include Beacon Therapeutics, Purespring Therapeutics, iOnctura.
What was Syncona Limited's most recent investment shown here?
Syncona Limited's most recent investment in this portfolio sample was in Purespring Therapeutics in 2024.
What sectors does Syncona Limited focus on?
Syncona Limited focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Syncona Limited focus on?
Syncona Limited typically invests at the Mid stage.
What is Syncona Limited's AUM?
Syncona Limited's assets under management are estimated between $1.3B and $1.3B.